OnCore Login

News & Developments

Across the Consortium: July 2021
Across the Consoritum Featured Investigators

July 22, 2021:

In this month’s Across the Consortium, get to know some the cancer investigators in the Big Ten, what doctoral candidates and graduate students are researching, what publications and accolades have been shared with Big Ten researchers, and more.

Read More

Chan, Phadke named breast cancer working group co-chairs

July 21, 2021: The Big Ten Cancer Research Consortium recently appointed Nancy Chan, MD (pictured right), a medical oncologist from Rutgers Cancer Institute of New Jersey, and Sneha Phadke, DO, MPH, (pictured left), a medical oncologist from University of Iowa Holden Comprehensive Cancer Center, as co-chairs of Big Ten CRC’s Breast Cancer Clinical Trial Working Group (CTWG). Their leadership supports collaboration and mentorship within the working group, as well as development of Big Ten CRC breast cancer clinical trials from conception to completion. CTWG co-chairs serve two-year terms that are... Read More

Janakiram, Suvannasankha named multiple myeloma co-chairs

July 8, 2021: Murali Janakiram, MD, MS, a medical oncologist at the Masonic Cancer Center, University of Minnesota, and Attaya Suvannasankha, MD, a medical oncologist at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, have been named co-chairs of the Big Ten Cancer Research Consortium’s Multiple Myeloma Clinical Trial Working Group. Dr. Janakiram is a graduate of Madras Medical College in Chennai, India. He completed his residency at Case Western University and MetroHealth Medical Center in Cleveland, Ohio, and his fellowship at Montefiore Medical Center,... Read More

Big Ten cancer researchers aim to close gaps, break barriers in AYA research and care

July 8, 2021: Big Ten Cancer Research Consortium investigators are determined to give adolescents and young adults (AYA) a fair shot in overcoming cancer by addressing the systemic challenges that are often roadblocks to the best care, including access to cancer clinical trials. AYAs range in age between 15 to 39. According to the National Cancer Institute, an estimated 88,260 new cases of cancer will be diagnosed among AYAs and about 85% of AYAs diagnosed with cancer will survive their cancer beyond five years after their diagnosis, some left with chronic side effects and fertility issues. Incidence of cancer... Read More

Population science group explores research opportunities from prevention to survivorship

July 7, 2021: Within the Big Ten Cancer Research Consortium, disease-specific Clinical Trial Working Groups are largely focused on developing novel therapeutics to treat and ultimately cure disease. The Big Ten CRC’s Population Science Working Group, led by co-chairs Sharon Manne, PhD, of Rutgers Cancer Institute of New Jersey and Electra Paskett, PhD, of The Ohio State University, has a different goal: To develop and implement population-based research within the Big Ten CRC. “The ultimate goal of our working group is to develop and implement research that reduces the cancer burden in the Big Ten,” said Dr. Manne (pictured left), Chief of Behavioral Sciences and co-Director of the... Read More

Big Ten CRC researchers report on phase Ib AML study during AACR

July 6, 2021: Big Ten Cancer Research Consortium investigators presented a poster highlighting the BTCRC-AML17-113 study during the American Association for Cancer Research Annual Meeting 2021. Led by John Quigley, MD, of the University of Illinois Cancer Center, the single-arm, open-label, multi-center phase Ib, dose-escalation study examines the safety and efficacy of gemtuzumab ozogamicin and venetoclax in patients with relapsed or refractory CD33+ acute myeloid leukemia. At the time the abstract was presented in April, researchers reported... Read More

Member Feature: Indiana University Melvin and Bren Simon Comprehensive Cancer Center

June 29, 2021: During the month of July, the Big Ten Cancer Research Consortium highlights the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, and cancer center member Paul Christian Mayor, MD, MS, FACOG. Paul Christian Mayor, MD, MS, FACOG Assistant Professor of Clinical Obstetrics and Gynecology Indiana University School of Medicine Educational Background Medical Degree: Medical College of Georgia, Augusta University Residency: Indiana University School of Medicine Fellowship: Roswell Park Comprehensive Cancer Center Read More

Across the Consortium: June 2021

June 27, 2021: In this edition of Across the Consortium, the Big Ten Cancer Research Consortium highlights cancer research ranging from scientists studying links between high cholesterol and breast cancer recurrence to "brain fog" and cognitive dysfunction after chemotherapy. We also share a study on the use of a robotic breast surgery option that may result in improved cosmetic outcomes without compromising cancer control, and how social media is influencing parents’ decisions about whether their children will or will not get the HPV Vaccine. Explore these studies, new appointments, publications, and other general news across the Big Ten CRC. Read More

RWJBarnabas Health, Rutgers Cancer Institute of New Jersey break ground on state’s first freestanding cancer hospital

June 24, 2021: Earlier today, RWJBarnabas Health and Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, in partnership with the New Brunswick Development Corporation, broke ground on the state’s first freestanding cancer hospital. At the ceremony, it was also announced that the 510,000-square-foot structure will be named the Jack and Sheryl Morris Cancer Center in recognition of the philanthropic leadership of Jack Morris, who has been a longtime supporter and pillar in New Brunswick development, and his wife, Sheryl. The 12-story facility, to be located on Somerset Street, will house inpatient, outpatient and ancillary services, as well as state-of-the-art laboratories where research faculty can provide hands-on educational opportunities for... Read More

Parkes appointed co-chair of Big Ten CRC AYA and Sarcoma Working Groups

June 18, 2021: Amanda Parkes, MD, a medical oncologist specializing in sarcoma and breast cancer at the University of Wisconsin Carbone Cancer Center, has been named co-chair of the Big Ten Cancer Research Consortium’s Adolescent and Young Adult (AYA) Clinical Trial Working Group and the Sarcoma Clinical Trial Working Group. Dr. Parkes, an assistant professor at University of Wisconsin School of Medicine and Public Health, has been a member of the consortium’s Breast Cancer Clinical Trial Working Group and the Sarcoma Clinical Trial Working Group since 2018. She has also participated as an investigator in several Big Ten CRC breast cancer trials and is leading the new breast... Read More

University of Illinois

University of Illinois

Indiana University

Indiana University

University of Iowa

University of Iowa

University of Maryland

University of Maryland

University of Michigan

University of Michigan

Michigan State

Michigan State

University of Minnesota

University of Minnesota

University of Nebraska

University of Nebraska

Northwestern University

Northwestern University

Penn State University

Penn State University

Purdue University

Purdue University

Rutgers State University

Rutgers State University

University of Washington

University of Washington

University of Wisconsin

University of Wisconsin

University of Illinois at Chicago

University of Illinois at Chicago

© 2025 All rights reserved.

Big Ten Cancer Research Consortium
7676 Interactive Way, Suite 120, Indianapolis, IN 46278

email: info@bigtencrc.org    phone: 317–921–2050